COVID-19 risks in rheumatic disease remain unclearNovember 7, 2020Psoriatic ArthritisCOVID-19 Updates
Biologics may protect psoriasis patients against severe COVID-19November 2, 2020COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Data on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020PsoriasisCOVID-19 UpdatesPsoriatic Arthritis
Non-Whites remain sorely underrepresented in phase 3 psoriasis trialsOctober 20, 2020PsoriasisPsoriatic Arthritis
Guselkumab improvements for psoriatic arthritis persist through 1 yearOctober 15, 2020Psoriatic Arthritis
Study highlights differences between White and Latino patients with psoriasisOctober 6, 2020PsoriasisPsoriatic Arthritis
Shingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020Psoriatic ArthritisPsoriasis
Golimumab approval extended to polyarticular-course JIA and juvenile PsAOctober 2, 2020Psoriatic ArthritisPediatricsRare Diseases
Study results suggest ustekinumab may trigger acute CV events early in treatmentSeptember 18, 2020PsoriasisPsoriatic Arthritis
Biologics for psoriasis may also reduce coronary plaqueSeptember 17, 2020PsoriasisPsoriatic Arthritis
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexateSeptember 16, 2020COVID-19 UpdatesPsoriasisPsoriatic Arthritis
